Clinical Report: Traditional Chinese Medicine's Mechanism Against Neonatal Pneumonia

Overview

This study systematically analyzes the efficacy of traditional Chinese medicine (TCM) in treating neonatal pneumonia, identifying naringenin as a key active component that targets MAPK1. The findings support the clinical application of TCM as a potential adjuvant therapy for neonatal pneumonia.

Background

Neonatal pneumonia is a significant cause of morbidity and mortality in neonates, particularly in vulnerable populations such as preterm infants. Current treatments primarily rely on antibiotics, which can lead to resistance and adverse effects. Therefore, exploring alternative therapies like TCM is essential for improving outcomes in neonatal pneumonia management.

Data Highlights

Key Findings

• TCM bath composed of Perilla frutescens, Radix Bupleuri, Mentha haplocalyx, and Schizonepeta tenuifolia shows significant clinical efficacy.
• MAPK1 was identified as a key hub gene involved in inflammatory and immune pathways.
• Naringenin demonstrated strong binding affinity to MAPK1 through molecular docking analysis.
• In vitro studies showed that naringenin and MAPK1 knockdown significantly reduced IL-6, IL-17, and TNF-α production.
• A mild synergistic effect was observed with combined treatment of naringenin and MAPK1 knockdown.

Clinical Implications

The findings suggest that naringenin could be a valuable component in TCM formulations for treating neonatal pneumonia. Clinicians may consider integrating TCM approaches alongside conventional therapies to enhance treatment efficacy and reduce reliance on antibiotics.

Conclusion

Highlight the necessity for further clinical trials and address study limitations.

Related Resources & Content

1. Frontiers in Cardiovascular Medicine, 2026 -- The effectiveness and safety of oral Chinese patent medicines in treating myocardial infarction complicated with heart failure: a network meta-analysis of 12 interventions
2. Open Forum Infectious Diseases -- Investigating Gene Expression Markers Linked to Neutrophil Extracellular Traps for Assessing Mortality Risk in Neonatal Sepsis
3. Frontiers in Oncology, 2026 -- Exploring the molecular mechanism of Coptis-cinnamon in combating gastric cancer via the MAPK Pathway based on network pharmacology
4. Management of Neonates Born at ≥35 0/7 Weeks’ Gestation With Suspected or Proven Early-Onset Bacterial Sepsis | Pediatrics | American Academy of Pediatrics
5. Archives of Toxicology — Induction of the Nrf2 Pathway by Hepatotoxic Medications is Linked to Inhibition of NF-κB Activation and Increased Vulnerability to TNFα-Induced Cell Death
6. Efficacy and safety of a Chinese herbal formula Maxing Ganshi Decoction in children with community-acquired pneumonia: A randomized, double-blind, placebo-controlled, multicenter trial
7. Ventilator-Associated Pneumonia in the Neonatal Intensive Care Unit—Incidence and Strategies for Prevention
8. Management of Neonates Born at ≥35 0/7 Weeks’ Gestation With Suspected or Proven Early-Onset Bacterial Sepsis | Pediatrics | American Academy of Pediatrics